Logo image of MEDI.OL

MEDISTIM ASA (MEDI.OL) Stock Price, Quote, News and Overview

OSL:MEDI - Euronext Oslo - NO0010159684 - Common Stock - Currency: NOK

160  -3 (-1.84%)

MEDI.OL Quote, Performance and Key Statistics

MEDISTIM ASA

OSL:MEDI (4/25/2025, 7:00:00 PM)

160

-3 (-1.84%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High203
52 Week Low130
Market Cap2.93B
Shares18.34M
Float13.57M
Yearly Dividend4.5
Dividend Yield3.68%
PE28.22
Fwd PE27.38
Earnings (Next)05-09 2025-05-09
IPO05-28 2004-05-28


MEDI.OL short term performance overview.The bars show the price performance of MEDI.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10

MEDI.OL long term performance overview.The bars show the price performance of MEDI.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of MEDI.OL is 160 NOK. In the past month the price decreased by -13.28%. In the past year, price decreased by -8.57%.

MEDISTIM ASA / MEDI Daily stock chart

MEDI.OL Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 26.78 195.04B
IUI1.DE INTUITIVE SURGICAL INC 69.6 160.59B
1ISRG.MI INTUITIVE SURGICAL INC 67.37 155.44B
BSX.DE BOSTON SCIENTIFIC CORP 40.27 131.64B
2M6.DE MEDTRONIC PLC 15.7 94.46B
SHL.DE SIEMENS HEALTHINEERS AG 20.82 52.84B
BOX.DE BECTON DICKINSON AND CO 14.61 51.31B
EWL.DE EDWARDS LIFESCIENCES CORP 28.95 39.15B
DC4.DE DEXCOM INC 43.32 24.63B
PHI1.DE KONINKLIJKE PHILIPS NV 15.88 20.74B
PHIA.AS KONINKLIJKE PHILIPS NV 15.87 20.74B
BIM.PA BIOMERIEUX 29.92 13.67B

About MEDI.OL

Company Profile

MEDI logo image Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.

Company Info

MEDISTIM ASA

Okernveien 94

Oslo OSLO NO

Employees: 154

Company Website: https://medistim.com/

Investor Relations: http://medistim.com/investor-relations/

Phone: 4723059660

MEDISTIM ASA / MEDI.OL FAQ

What is the stock price of MEDISTIM ASA today?

The current stock price of MEDI.OL is 160 NOK. The price decreased by -1.84% in the last trading session.


What is the ticker symbol for MEDISTIM ASA stock?

The exchange symbol of MEDISTIM ASA is MEDI and it is listed on the Euronext Oslo exchange.


On which exchange is MEDI.OL stock listed?

MEDI.OL stock is listed on the Euronext Oslo exchange.


What is the price forecast or stock price prediction for MEDISTIM ASA stock?

9 analysts have analysed MEDI.OL and the average price target is 175.44 NOK. This implies a price increase of 9.65% is expected in the next year compared to the current price of 160. Check the MEDISTIM ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MEDISTIM ASA worth?

MEDISTIM ASA (MEDI.OL) has a market capitalization of 2.93B NOK. This makes MEDI.OL a Mid Cap stock.


How many employees does MEDISTIM ASA have?

MEDISTIM ASA (MEDI.OL) currently has 154 employees.


What are the support and resistance levels for MEDISTIM ASA (MEDI.OL) stock?

MEDISTIM ASA (MEDI.OL) has a support level at 159.99 and a resistance level at 161.95. Check the full technical report for a detailed analysis of MEDI.OL support and resistance levels.


Is MEDISTIM ASA (MEDI.OL) expected to grow?

The Revenue of MEDISTIM ASA (MEDI.OL) is expected to grow by 8.3% in the next year. Check the estimates tab for more information on the MEDI.OL EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MEDISTIM ASA (MEDI.OL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MEDISTIM ASA (MEDI.OL) stock pay dividends?

MEDISTIM ASA (MEDI.OL) has a dividend yield of 3.68%. The yearly dividend amount is currently 4.5. Check the full fundamental report for a detailed analysis of MEDI.OL dividend history, reliability and sustainability.


When does MEDISTIM ASA (MEDI.OL) report earnings?

MEDISTIM ASA (MEDI.OL) will report earnings on 2025-05-09.


What is the Price/Earnings (PE) ratio of MEDISTIM ASA (MEDI.OL)?

The PE ratio for MEDISTIM ASA (MEDI.OL) is 28.22. This is based on the reported non-GAAP earnings per share of 5.67 and the current share price of 160 NOK. Check the full fundamental report for a full analysis of the valuation metrics for MEDI.OL.


MEDI.OL Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to MEDI.OL. When comparing the yearly performance of all stocks, MEDI.OL turns out to be only a medium performer in the overall market: it outperformed 51.95% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MEDI.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to MEDI.OL. MEDI.OL scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MEDI.OL Financial Highlights

Over the last trailing twelve months MEDI.OL reported a non-GAAP Earnings per Share(EPS) of 5.67. The EPS decreased by -0.06% compared to the year before.


Industry RankSector Rank
PM (TTM) 18.46%
ROA 18.06%
ROE 23.78%
Debt/Equity 0.06
Chartmill High Growth Momentum
EPS Q2Q%11.54%
Sales Q2Q%11.44%
EPS 1Y (TTM)-0.06%
Revenue 1Y (TTM)6.88%

MEDI.OL Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 42% to MEDI.OL. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 7.04% and a revenue growth 8.3% for MEDI.OL


Ownership
Inst Owners60.75%
Ins Owners2.83%
Short Float %N/A
Short RatioN/A
Analysts
Analysts42.22
Price Target175.44 (9.65%)
EPS Next Y7.04%
Revenue Next Year8.3%